epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Invega Trinza

paliperidone palmitate

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Dementia-Related Psychosis

not approved for dementia-related psychosis; incr. mortality risk in elderly patients on antipsychotic tx for dementia-related psychosis; most deaths due to cardiovascular or infectious events

Adult Dosing .

Dosage forms:  INJ (pre-filled syringe): 273 mg per 0.875 mL, 410 mg per 1.315 mL, 546 mg per 1.75 mL, 819 mg per 2.625 mL

schizophrenia

[conversion from paliperidone palmitate 78 mg/mo IM]
Dose: 273 mg IM q3mo; Start: at next scheduled dose after at least 4mo tx with 1-mo IM paliperidone palmitate form (last 2 doses same strength); Max: 819 mg/dose; Info: may adjust dose q3mo; see pkg insert for missed dose recommendations and conversion to oral paliperidone; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[conversion from paliperidone palmitate 117 mg/mo IM]
Dose: 410 mg IM q3mo; Start: at next scheduled dose after at least 4mo tx with 1-mo IM paliperidone palmitate form (last 2 doses same strength); Max: 819 mg/dose; Info: may adjust dose q3mo; see pkg insert for missed dose recommendations and conversion to oral paliperidone; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[conversion from paliperidone palmitate 156 mg/mo IM]
Dose: 546 mg IM q3mo; Start: at next scheduled dose after at least 4mo tx with 1-mo IM paliperidone palmitate form (last 2 doses same strength); Max: 819 mg/dose; Info: may adjust dose q3mo; see pkg insert for missed dose recommendations and conversion to oral paliperidone; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[conversion from paliperidone palmitate 234 mg/mo IM]
Dose: 819 mg IM q3mo; Start: at next scheduled dose after at least 4mo tx with 1-mo IM paliperidone palmitate form (last 2 doses same strength); Max: 819 mg/dose; Info: may adjust dose q3mo; see pkg insert for missed dose recommendations and conversion to oral paliperidone; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC

renal dosing

[see below]
CrCl 50-79: adjust dose using 1-mo IM paliperidone palmitate form prior to conversion; CrCl <50: avoid use
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@54dc61a9
  • hypersensitivity to drug or ingredient
  • hypersensitivity to risperidone
  • CrCl <50
  • long QT syndrome, congenital
  • arrhythmia history
  • caution: bradycardia
  • caution: hypokalemia
  • caution: hypomagnesemia
  • caution: QT prolongation
  • caution: QT prolongation family history
  • caution: MI, recent
  • caution: CHF
  • caution: CNS depressant use, concurrent
  • caution: alcohol use, concurrent
  • caution: elderly patients
  • caution: leukopenia
  • caution: leukopenia history, drug-induced
  • caution: neutropenia
  • caution: neutropenia history, drug-induced
  • caution: CrCl 50-79
  • caution: cardiovascular disease
  • caution: cerebrovascular disease
  • caution: psychosis, dementia-associated
  • caution: dementia with Lewy bodies
  • caution: Parkinson disease
  • caution: diabetes mellitus
  • caution: diabetes mellitus risk
  • caution: hypovolemia
  • caution: dehydration
  • caution: hypotension risk
  • caution: seizure history
  • caution: seizure risk
  • caution: aspiration pneumonia risk
  • caution: environmental temperature, high

Drug Interactions .

Overview

paliperidone

atypical antipsychotic

Interaction Characteristics:
  • CYP3A4 substrate
  • P-gp substrate
  • CNS depression
  • decreases central histamine effects
  • dopamine antagonist
  • extrapyramidal effects
  • hyperglycemic effects
  • hyperprolactinemic effects
  • hyperthermia
  • hypotensive effects
  • lowers seizure threshold
  • prolongs QT interval (known)

Contraindicated

  • cisapride
  • Invega Trinza (paliperidone palmitate)
    +
    cisapride
    1 interaction

    Contraindicated

    paliperidone + cisapride

    contraindicated: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • domperidone
  • Invega Trinza (paliperidone palmitate)
    +
    domperidone
    1 interaction

    Contraindicated

    paliperidone + domperidone

    contraindicated: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • dronedarone
  • Invega Trinza (paliperidone palmitate)
    +
    dronedarone
    1 interaction

    Contraindicated

    paliperidone + dronedarone

    contraindicated: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • levoketoconazole
  • Invega Trinza (paliperidone palmitate)
    +
    levoketoconazole
    1 interaction

    Contraindicated

    paliperidone + levoketoconazole

    contraindicated: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pimozide
  • Invega Trinza (paliperidone palmitate)
    +
    pimozide
    1 interaction

    Contraindicated

    paliperidone + pimozide

    contraindicated: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • thioridazine
  • Invega Trinza (paliperidone palmitate)
    +
    thioridazine
    1 interaction

    Contraindicated

    paliperidone + thioridazine

    contraindicated: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

Avoid/Use Alternative

  • adagrasib
  • Invega Trinza (paliperidone palmitate)
    +
    adagrasib
    1 interaction

    Avoid/Use Alternative

    paliperidone + adagrasib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • aldesleukin
  • Invega Trinza (paliperidone palmitate)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    paliperidone + aldesleukin

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, severe or life-threatening hypotension (including orthostasis, syncope), seizures (additive effects)

  • amifampridine
  • Invega Trinza (paliperidone palmitate)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    paliperidone + amifampridine

    consider alternative: combo may incr. risk of seizures (additive effects)

  • amiodarone
  • Invega Trinza (paliperidone palmitate)
    +
    amiodarone
    1 interaction

    Avoid/Use Alternative

    paliperidone + amiodarone

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • anagrelide
  • Invega Trinza (paliperidone palmitate)
    +
    anagrelide
    1 interaction

    Avoid/Use Alternative

    paliperidone + anagrelide

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • apalutamide
  • Invega Trinza (paliperidone palmitate)
    +
    apalutamide
    1 interaction

    Avoid/Use Alternative

    paliperidone + apalutamide

    use alternative or monitor ECG, consider oral paliperidone dose adjustment: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. paliperidone levels, efficacy (additive effects; hepatic metabolism induced, P-gp-mediated transport induced)

  • apomorphine
  • Invega Trinza (paliperidone palmitate)
    +
    apomorphine
    1 interaction

    Avoid/Use Alternative

    paliperidone + apomorphine

    use alternative or monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • aripiprazole bimonthly injection
  • Invega Trinza (paliperidone palmitate)
    +
    aripiprazole bimonthly injection
    1 interaction

    Avoid/Use Alternative

    paliperidone + aripiprazole bimonthly injection

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole lauroxil
  • Invega Trinza (paliperidone palmitate)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    paliperidone + aripiprazole lauroxil

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole monthly injection
  • Invega Trinza (paliperidone palmitate)
    +
    aripiprazole monthly injection
    1 interaction

    Avoid/Use Alternative

    paliperidone + aripiprazole monthly injection

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole oral
  • Invega Trinza (paliperidone palmitate)
    +
    aripiprazole oral
    1 interaction

    Avoid/Use Alternative

    paliperidone + aripiprazole oral

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • arsenic trioxide
  • Invega Trinza (paliperidone palmitate)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    paliperidone + arsenic trioxide

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • artemether/lumefantrine
  • Invega Trinza (paliperidone palmitate)
    +
    artemether/ lumefantrine
    1 interaction

    Avoid/Use Alternative

    paliperidone + artemether/ lumefantrine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • asenapine
  • Invega Trinza (paliperidone palmitate)
    +
    asenapine
    1 interaction

    Avoid/Use Alternative

    paliperidone + asenapine

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • azithromycin
  • Invega Trinza (paliperidone palmitate)
    +
    azithromycin
    1 interaction

    Avoid/Use Alternative

    paliperidone + azithromycin

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • bedaquiline
  • Invega Trinza (paliperidone palmitate)
    +
    bedaquiline
    1 interaction

    Avoid/Use Alternative

    paliperidone + bedaquiline

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • benztropine
  • Invega Trinza (paliperidone palmitate)
    +
    benztropine
    1 interaction

    Avoid/Use Alternative

    paliperidone + benztropine

    consider alternative: combo may incr. risk of hyperthermia, including life-threatening (additive effects)

  • bromocriptine
  • Invega Trinza (paliperidone palmitate)
    +
    bromocriptine
    1 interaction

    Avoid/Use Alternative

    paliperidone + bromocriptine

    use alternative or monitor BP, glucose (type 2 diabetes mellitus pts): combo may decr. efficacy of both drugs; may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • butalbital
  • Invega Trinza (paliperidone palmitate)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    paliperidone + butalbital

    IM PALIPERIDONE: use alternative or monitor respiratory rate; ORAL PALIPERIDONE: monitor respiratory rate, consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • cabergoline
  • Invega Trinza (paliperidone palmitate)
    +
    cabergoline
    1 interaction

    Avoid/Use Alternative

    paliperidone + cabergoline

    use alternative or monitor BP: combo may decr. efficacy of both drugs; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • cabozantinib
  • Invega Trinza (paliperidone palmitate)
    +
    cabozantinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + cabozantinib

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • carbamazepine
  • Invega Trinza (paliperidone palmitate)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    paliperidone + carbamazepine

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: monitor BP; consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS depression, psychomotor impairment, hypotension, including syncope; may alter seizure control (hepatic metabolism induced; P-gp-mediated transport induced; additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • ceritinib
  • Invega Trinza (paliperidone palmitate)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + ceritinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • chloroquine
  • Invega Trinza (paliperidone palmitate)
    +
    chloroquine
    1 interaction

    Avoid/Use Alternative

    paliperidone + chloroquine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, extrapyramidal symptoms (additive effects)

  • ciprofloxacin
  • Invega Trinza (paliperidone palmitate)
    +
    ciprofloxacin
    1 interaction

    Avoid/Use Alternative

    paliperidone + ciprofloxacin

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • citalopram
  • Invega Trinza (paliperidone palmitate)
    +
    citalopram
    1 interaction

    Avoid/Use Alternative

    paliperidone + citalopram

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • clarithromycin
  • Invega Trinza (paliperidone palmitate)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    paliperidone + clarithromycin

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • clofazimine
  • Invega Trinza (paliperidone palmitate)
    +
    clofazimine
    1 interaction

    Avoid/Use Alternative

    paliperidone + clofazimine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • clonidine
  • Invega Trinza (paliperidone palmitate)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    paliperidone + clonidine

    if ADHD use, avoid combo; otherwise, monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • codeine
  • Invega Trinza (paliperidone palmitate)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    paliperidone + codeine

    avoid combo if antitussive use; otherwise monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • crizotinib
  • Invega Trinza (paliperidone palmitate)
    +
    crizotinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + crizotinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • danshen
  • Invega Trinza (paliperidone palmitate)
    +
    danshen
    1 interaction

    Avoid/Use Alternative

    paliperidone + danshen

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport induced)

  • degarelix
  • Invega Trinza (paliperidone palmitate)
    +
    degarelix
    1 interaction

    Avoid/Use Alternative

    paliperidone + degarelix

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects, androgen deprivation may prolong QT)

  • desflurane
  • Invega Trinza (paliperidone palmitate)
    +
    desflurane
    1 interaction

    Avoid/Use Alternative

    paliperidone + desflurane

    use alternative or monitor ECG, respiratory rate, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS and respiratory depression, psychomotor impairment (additive effects)

  • desipramine
  • Invega Trinza (paliperidone palmitate)
    +
    desipramine
    1 interaction

    Avoid/Use Alternative

    paliperidone + desipramine

    use alternative or monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dexmedetomidine
  • Invega Trinza (paliperidone palmitate)
    +
    dexmedetomidine
    1 interaction

    Avoid/Use Alternative

    paliperidone + dexmedetomidine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Invega Trinza (paliperidone palmitate)
    +
    dexmedetomidine injection
    1 interaction

    Avoid/Use Alternative

    paliperidone + dexmedetomidine injection

    use alternative or monitor ECG, BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS and respiratory depression, psychomotor impairment, severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • diazepam
  • Invega Trinza (paliperidone palmitate)
    +
    diazepam
    1 interaction

    Avoid/Use Alternative

    paliperidone + diazepam

    use alternative or monitor BP, respiratory rate, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • dicloxacillin
  • Invega Trinza (paliperidone palmitate)
    +
    dicloxacillin
    1 interaction

    Avoid/Use Alternative

    paliperidone + dicloxacillin

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport induced)

  • disopyramide
  • Invega Trinza (paliperidone palmitate)
    +
    disopyramide
    1 interaction

    Avoid/Use Alternative

    paliperidone + disopyramide

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, hyperthermia (additive effects)

  • dofetilide
  • Invega Trinza (paliperidone palmitate)
    +
    dofetilide
    1 interaction

    Avoid/Use Alternative

    paliperidone + dofetilide

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • donepezil
  • Invega Trinza (paliperidone palmitate)
    +
    donepezil
    1 interaction

    Avoid/Use Alternative

    paliperidone + donepezil

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • dordaviprone
  • Invega Trinza (paliperidone palmitate)
    +
    dordaviprone
    1 interaction

    Avoid/Use Alternative

    paliperidone + dordaviprone

    use alternative or monitor ECG, electrolytes; separate admin.: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • doxylamine
  • Invega Trinza (paliperidone palmitate)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    paliperidone + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting, otherwise caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • droperidol
  • Invega Trinza (paliperidone palmitate)
    +
    droperidol
    1 interaction

    Avoid/Use Alternative

    paliperidone + droperidol

    use alternative or monitor ECG; decr. dose of one or both drugs: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • efavirenz
  • Invega Trinza (paliperidone palmitate)
    +
    efavirenz
    1 interaction

    Avoid/Use Alternative

    paliperidone + efavirenz

    IM PALIPERIDONE: use alternative or monitor ECG; ORAL PALIPERIDONE: monitor ECG, consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (P-gp-mediated transport induced; additive effects)

  • encorafenib
  • Invega Trinza (paliperidone palmitate)
    +
    encorafenib
    1 interaction

    Avoid/Use Alternative

    paliperidone + encorafenib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. paliperidone levels, efficacy (additive effects; hepatic metabolism induced)

  • entrectinib
  • Invega Trinza (paliperidone palmitate)
    +
    entrectinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + entrectinib

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment (additive effects)

  • enzalutamide
  • Invega Trinza (paliperidone palmitate)
    +
    enzalutamide
    1 interaction

    Avoid/Use Alternative

    paliperidone + enzalutamide

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (hepatic metabolism induced)

  • ephedra
  • Invega Trinza (paliperidone palmitate)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    paliperidone + ephedra

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • epirubicin
  • Invega Trinza (paliperidone palmitate)
    +
    epirubicin
    1 interaction

    Avoid/Use Alternative

    paliperidone + epirubicin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • eribulin
  • Invega Trinza (paliperidone palmitate)
    +
    eribulin
    1 interaction

    Avoid/Use Alternative

    paliperidone + eribulin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • erythromycin
  • Invega Trinza (paliperidone palmitate)
    +
    erythromycin
    1 interaction

    Avoid/Use Alternative

    paliperidone + erythromycin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • ethanol (alcoholic beverage)
  • Invega Trinza (paliperidone palmitate)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    paliperidone + ethanol (alcoholic beverage)

    avoid combo: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ethanol injection
  • Invega Trinza (paliperidone palmitate)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    paliperidone + ethanol injection

    use alternative or monitor respiratory rate, BP: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • etrasimod
  • Invega Trinza (paliperidone palmitate)
    +
    etrasimod
    1 interaction

    Avoid/Use Alternative

    paliperidone + etrasimod

    consider alternative or monitor HR, ECG: combo may incr. risk of bradycardia, AV block, QT prolongation, cardiac arrhythmias (additive effects)

  • fexinidazole
  • Invega Trinza (paliperidone palmitate)
    +
    fexinidazole
    1 interaction

    Avoid/Use Alternative

    paliperidone + fexinidazole

    if possible, do not initiate fexinidazole until 5 half-lives after paliperidone D/C; use alternative or monitor ECG during and x7 days after fexinidazole tx: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • flecainide
  • Invega Trinza (paliperidone palmitate)
    +
    flecainide
    1 interaction

    Avoid/Use Alternative

    paliperidone + flecainide

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • fluorouracil
  • Invega Trinza (paliperidone palmitate)
    +
    fluorouracil
    1 interaction

    Avoid/Use Alternative

    paliperidone + fluorouracil

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • fluoxetine
  • Invega Trinza (paliperidone palmitate)
    +
    fluoxetine
    1 interaction

    Avoid/Use Alternative

    paliperidone + fluoxetine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • foscarnet
  • Invega Trinza (paliperidone palmitate)
    +
    foscarnet
    1 interaction

    Avoid/Use Alternative

    paliperidone + foscarnet

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • fosfomycin injection
  • Invega Trinza (paliperidone palmitate)
    +
    fosfomycin injection
    1 interaction

    Avoid/Use Alternative

    paliperidone + fosfomycin injection

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • fosphenytoin
  • Invega Trinza (paliperidone palmitate)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    paliperidone + fosphenytoin

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; P-gp-mediated transport induced; additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • gepotidacin
  • Invega Trinza (paliperidone palmitate)
    +
    gepotidacin
    1 interaction

    Avoid/Use Alternative

    paliperidone + gepotidacin

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • gilteritinib
  • Invega Trinza (paliperidone palmitate)
    +
    gilteritinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + gilteritinib

    use alternative or monitor ECG, electrolytes, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope (additive effects)

  • givinostat
  • Invega Trinza (paliperidone palmitate)
    +
    givinostat
    1 interaction

    Avoid/Use Alternative

    paliperidone + givinostat

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • glasdegib
  • Invega Trinza (paliperidone palmitate)
    +
    glasdegib
    1 interaction

    Avoid/Use Alternative

    paliperidone + glasdegib

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • goserelin
  • Invega Trinza (paliperidone palmitate)
    +
    goserelin
    1 interaction

    Avoid/Use Alternative

    paliperidone + goserelin

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. goserelin efficacy (additive effects, androgen deprivation may prolong QT; paliperidone may cause hyperprolactinemia, decr. GnRH receptors)

  • grapefruit
  • Invega Trinza (paliperidone palmitate)
    +
    grapefruit
    1 interaction

    Avoid/Use Alternative

    paliperidone + grapefruit

    use alternative or monitor ECG w/ large amounts of grapefruit (>1L juice): combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • haloperidol
  • Invega Trinza (paliperidone palmitate)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    paliperidone + haloperidol

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • histrelin
  • Invega Trinza (paliperidone palmitate)
    +
    histrelin
    1 interaction

    Avoid/Use Alternative

    paliperidone + histrelin

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. histrelin efficacy (additive effects, androgen deprivation may prolong QT; paliperidone may cause hyperprolactinemia, decr. GnRH receptors)

  • hydrocodone
  • Invega Trinza (paliperidone palmitate)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    paliperidone + hydrocodone

    avoid combo if antitussive use; otherwise monitor respiratory rate, BP, ECG, electrolytes, especially if hydrocodone ER doses >160 mg/day; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxychloroquine
  • Invega Trinza (paliperidone palmitate)
    +
    hydroxychloroquine
    1 interaction

    Avoid/Use Alternative

    paliperidone + hydroxychloroquine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • hydroxyzine
  • Invega Trinza (paliperidone palmitate)
    +
    hydroxyzine
    1 interaction

    Avoid/Use Alternative

    paliperidone + hydroxyzine

    use alternative or monitor ECG; consider decr. dose of one or both drugs: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ibutilide
  • Invega Trinza (paliperidone palmitate)
    +
    ibutilide
    1 interaction

    Avoid/Use Alternative

    paliperidone + ibutilide

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • iloperidone
  • Invega Trinza (paliperidone palmitate)
    +
    iloperidone
    1 interaction

    Avoid/Use Alternative

    paliperidone + iloperidone

    use alternative or monitor ECG, BP, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • inotuzumab ozogamicin
  • Invega Trinza (paliperidone palmitate)
    +
    inotuzumab ozogamicin
    1 interaction

    Avoid/Use Alternative

    paliperidone + inotuzumab ozogamicin

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • isocarboxazid
  • Invega Trinza (paliperidone palmitate)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    paliperidone + isocarboxazid

    use alternative or monitor BP during and x10 days after isocarboxazid use: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • isoflurane
  • Invega Trinza (paliperidone palmitate)
    +
    isoflurane
    1 interaction

    Avoid/Use Alternative

    paliperidone + isoflurane

    use alternative or monitor ECG, BP, respiratory rate: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS and respiratory depression, psychomotor impairment (additive effects)

  • ivabradine
  • Invega Trinza (paliperidone palmitate)
    +
    ivabradine
    1 interaction

    Avoid/Use Alternative

    paliperidone + ivabradine

    consider alternative or monitor HR, ECG: combo may incr. risk of bradycardia, AV block, QT prolongation, cardiac arrhythmias (additive effects)

  • ivosidenib
  • Invega Trinza (paliperidone palmitate)
    +
    ivosidenib
    1 interaction

    Avoid/Use Alternative

    paliperidone + ivosidenib

    avoid combo: combo may decr. paliperidone levels, efficacy; may incr. risk of QT prolongation, cardiac arrhythmias (hepatic metabolism induced; additive effects)

  • kava
  • Invega Trinza (paliperidone palmitate)
    +
    kava
    1 interaction

    Avoid/Use Alternative

    paliperidone + kava

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • kratom
  • Invega Trinza (paliperidone palmitate)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    paliperidone + kratom

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • lefamulin
  • Invega Trinza (paliperidone palmitate)
    +
    lefamulin
    1 interaction

    Avoid/Use Alternative

    paliperidone + lefamulin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • leuprolide
  • Invega Trinza (paliperidone palmitate)
    +
    leuprolide
    1 interaction

    Avoid/Use Alternative

    paliperidone + leuprolide

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. leuprolide efficacy (additive effects, androgen deprivation may prolong QT; paliperidone may cause hyperprolactinemia, decr. GnRH receptors)

  • levofloxacin
  • Invega Trinza (paliperidone palmitate)
    +
    levofloxacin
    1 interaction

    Avoid/Use Alternative

    paliperidone + levofloxacin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • lofexidine
  • Invega Trinza (paliperidone palmitate)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    paliperidone + lofexidine

    use alternative or monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • lonafarnib
  • Invega Trinza (paliperidone palmitate)
    +
    lonafarnib
    1 interaction

    Avoid/Use Alternative

    paliperidone + lonafarnib

    use alternative or monitor HR, ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • loperamide
  • Invega Trinza (paliperidone palmitate)
    +
    loperamide
    1 interaction

    Avoid/Use Alternative

    paliperidone + loperamide

    use alternative or monitor ECG, esp. if loperamide dose >16mg/day: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • lopinavir/ritonavir
  • Invega Trinza (paliperidone palmitate)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    paliperidone + lopinavir/ ritonavir

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • lorlatinib
  • Invega Trinza (paliperidone palmitate)
    +
    lorlatinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + lorlatinib

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport induced)

  • lumacaftor/ivacaftor
  • Invega Trinza (paliperidone palmitate)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    paliperidone + lumacaftor/ ivacaftor

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (hepatic metabolism induced; P-gp-mediated transport possibly induced)

  • lumateperone
  • Invega Trinza (paliperidone palmitate)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    paliperidone + lumateperone

    use alternative or monitor BP, ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • lurasidone
  • Invega Trinza (paliperidone palmitate)
    +
    lurasidone
    1 interaction

    Avoid/Use Alternative

    paliperidone + lurasidone

    use alternative or monitor ECG, BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, other adverse effects (additive effects, duplicate therapy)

  • macimorelin
  • Invega Trinza (paliperidone palmitate)
    +
    macimorelin
    1 interaction

    Avoid/Use Alternative

    paliperidone + macimorelin

    avoid combo, allowing sufficient washout time before diagnostic test: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • metaxalone
  • Invega Trinza (paliperidone palmitate)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    paliperidone + metaxalone

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • methadone
  • Invega Trinza (paliperidone palmitate)
    +
    methadone
    1 interaction

    Avoid/Use Alternative

    paliperidone + methadone

    use alternative or monitor ECG, BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, severe hypotension, including orthostasis, syncope (additive effects)

  • metoclopramide
  • Invega Trinza (paliperidone palmitate)
    +
    metoclopramide
    1 interaction

    Avoid/Use Alternative

    paliperidone + metoclopramide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • midazolam
  • Invega Trinza (paliperidone palmitate)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    paliperidone + midazolam

    use alternative or monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • mifepristone
  • Invega Trinza (paliperidone palmitate)
    +
    mifepristone
    1 interaction

    Avoid/Use Alternative

    paliperidone + mifepristone

    use alternative or monitor ECG if daily mifepristone use: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • milsaperidone
  • Invega Trinza (paliperidone palmitate)
    +
    milsaperidone
    1 interaction

    Avoid/Use Alternative

    paliperidone + milsaperidone

    use alternative or monitor ECG, electrolytes, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • mitotane
  • Invega Trinza (paliperidone palmitate)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    paliperidone + mitotane

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • mobocertinib
  • Invega Trinza (paliperidone palmitate)
    +
    mobocertinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + mobocertinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • moxifloxacin
  • Invega Trinza (paliperidone palmitate)
    +
    moxifloxacin
    1 interaction

    Avoid/Use Alternative

    paliperidone + moxifloxacin

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • nilotinib
  • Invega Trinza (paliperidone palmitate)
    +
    nilotinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + nilotinib

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • olanzapine
  • Invega Trinza (paliperidone palmitate)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    paliperidone + olanzapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia, extrapyramidal symptoms, other adverse effects (additive effects, duplicate therapy)

  • oliceridine
  • Invega Trinza (paliperidone palmitate)
    +
    oliceridine
    1 interaction

    Avoid/Use Alternative

    paliperidone + oliceridine

    use alternative or monitor ECG, respiratory rate, BP: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, severe hypotension, including orthostasis, syncope (additive effects)

  • ondansetron
  • Invega Trinza (paliperidone palmitate)
    +
    ondansetron
    1 interaction

    Avoid/Use Alternative

    paliperidone + ondansetron

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • osimertinib
  • Invega Trinza (paliperidone palmitate)
    +
    osimertinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + osimertinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • oxaliplatin
  • Invega Trinza (paliperidone palmitate)
    +
    oxaliplatin
    1 interaction

    Avoid/Use Alternative

    paliperidone + oxaliplatin

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • oxybate
  • Invega Trinza (paliperidone palmitate)
    +
    oxybate
    1 interaction

    Avoid/Use Alternative

    paliperidone + oxybate

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • ozanimod
  • Invega Trinza (paliperidone palmitate)
    +
    ozanimod
    1 interaction

    Avoid/Use Alternative

    paliperidone + ozanimod

    consider alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pacritinib
  • Invega Trinza (paliperidone palmitate)
    +
    pacritinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + pacritinib

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • palonosetron
  • Invega Trinza (paliperidone palmitate)
    +
    palonosetron
    1 interaction

    Avoid/Use Alternative

    paliperidone + palonosetron

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pasireotide
  • Invega Trinza (paliperidone palmitate)
    +
    pasireotide
    1 interaction

    Avoid/Use Alternative

    paliperidone + pasireotide

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pazopanib
  • Invega Trinza (paliperidone palmitate)
    +
    pazopanib
    1 interaction

    Avoid/Use Alternative

    paliperidone + pazopanib

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pentamidine
  • Invega Trinza (paliperidone palmitate)
    +
    pentamidine
    1 interaction

    Avoid/Use Alternative

    paliperidone + pentamidine

    use alternative or monitor ECG, BP; risk may be lower w/ nebulized pentamidine: combo may incr. risk of QT prolongation, cardiac arrhythmias, severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Invega Trinza (paliperidone palmitate)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    paliperidone + pentobarbital

    IM PALIPERIDONE: use alternative or monitor respiratory rate, BP; ORAL PALIPERIDONE: monitor respiratory rate, BP, consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (hepatic metabolism induced; additive effects)

  • phenelzine
  • Invega Trinza (paliperidone palmitate)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    paliperidone + phenelzine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • phenobarbital
  • Invega Trinza (paliperidone palmitate)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    paliperidone + phenobarbital

    IM PALIPERIDONE: use alternative or monitor respiratory rate, BP, ECG; ORAL PALIPERIDONE: monitor respiratory rate, BP, ECG, consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope; may alter seizure control (hepatic metabolism induced, P-gp-mediated transport possibly induced; additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • phenytoin
  • Invega Trinza (paliperidone palmitate)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    paliperidone + phenytoin

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; P-gp-mediated transport induced; additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • pimavanserin
  • Invega Trinza (paliperidone palmitate)
    +
    pimavanserin
    1 interaction

    Avoid/Use Alternative

    paliperidone + pimavanserin

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects (additive effects, duplicate therapy)

  • pitolisant
  • Invega Trinza (paliperidone palmitate)
    +
    pitolisant
    1 interaction

    Avoid/Use Alternative

    paliperidone + pitolisant

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. pitolisant efficacy (additive effects; antagonistic effects)

  • ponesimod
  • Invega Trinza (paliperidone palmitate)
    +
    ponesimod
    1 interaction

    Avoid/Use Alternative

    paliperidone + ponesimod

    use alternative or monitor HR, ECG: combo may incr. risk of bradycardia, AV block, QT prolongation, cardiac arrhythmias (additive effects)

  • primidone
  • Invega Trinza (paliperidone palmitate)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    paliperidone + primidone

    IM PALIPERIDONE: use alternative or monitor respiratory rate; ORAL PALIPERIDONE: monitor respiratory rate, consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced, P-gp-mediated transport possibly induced; additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • procainamide
  • Invega Trinza (paliperidone palmitate)
    +
    procainamide
    1 interaction

    Avoid/Use Alternative

    paliperidone + procainamide

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • promethazine
  • Invega Trinza (paliperidone palmitate)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    paliperidone + promethazine

    use alternative or monitor ECG, BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS and respiratory depression, psychomotor impairment, seizures, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • propafenone
  • Invega Trinza (paliperidone palmitate)
    +
    propafenone
    1 interaction

    Avoid/Use Alternative

    paliperidone + propafenone

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope (additive effects)

  • quetiapine
  • Invega Trinza (paliperidone palmitate)
    +
    quetiapine
    1 interaction

    Avoid/Use Alternative

    paliperidone + quetiapine

    use alternative or monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • quinidine (antiarrhythmic)
  • Invega Trinza (paliperidone palmitate)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Avoid/Use Alternative

    paliperidone + quinidine (antiarrhythmic)

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • quinidine (CYP2D6 inhibitor)
  • Invega Trinza (paliperidone palmitate)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Avoid/Use Alternative

    paliperidone + quinidine (CYP2D6 inhibitor)

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • quinine
  • Invega Trinza (paliperidone palmitate)
    +
    quinine
    1 interaction

    Avoid/Use Alternative

    paliperidone + quinine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • quizartinib
  • Invega Trinza (paliperidone palmitate)
    +
    quizartinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + quizartinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • rasagiline
  • Invega Trinza (paliperidone palmitate)
    +
    rasagiline
    1 interaction

    Avoid/Use Alternative

    paliperidone + rasagiline

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • revumenib
  • Invega Trinza (paliperidone palmitate)
    +
    revumenib
    1 interaction

    Avoid/Use Alternative

    paliperidone + revumenib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • ribociclib
  • Invega Trinza (paliperidone palmitate)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    paliperidone + ribociclib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • rifabutin
  • Invega Trinza (paliperidone palmitate)
    +
    rifabutin
    1 interaction

    Avoid/Use Alternative

    paliperidone + rifabutin

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (hepatic metabolism induced; P-gp-mediated transport possibly induced)

  • rifampin
  • Invega Trinza (paliperidone palmitate)
    +
    rifampin
    1 interaction

    Avoid/Use Alternative

    paliperidone + rifampin

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (hepatic metabolism induced; P-gp-mediated transport possibly induced)

  • rifapentine
  • Invega Trinza (paliperidone palmitate)
    +
    rifapentine
    1 interaction

    Avoid/Use Alternative

    paliperidone + rifapentine

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport possibly induced)

  • rilpivirine
  • Invega Trinza (paliperidone palmitate)
    +
    rilpivirine
    1 interaction

    Avoid/Use Alternative

    paliperidone + rilpivirine

    consider alternative or monitor ECG; risk may be lower w/ IM rilpivirine: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • romidepsin
  • Invega Trinza (paliperidone palmitate)
    +
    romidepsin
    1 interaction

    Avoid/Use Alternative

    paliperidone + romidepsin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • ropeginterferon alfa-2b
  • Invega Trinza (paliperidone palmitate)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    paliperidone + ropeginterferon alfa-2b

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rucaparib
  • Invega Trinza (paliperidone palmitate)
    +
    rucaparib
    1 interaction

    Avoid/Use Alternative

    paliperidone + rucaparib

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • safinamide
  • Invega Trinza (paliperidone palmitate)
    +
    safinamide
    1 interaction

    Avoid/Use Alternative

    paliperidone + safinamide

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • scopolamine
  • Invega Trinza (paliperidone palmitate)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    paliperidone + scopolamine

    use alternative: combo may increase risk of CNS depression, psychomotor impairment, hyperthermia, including life-threatening (additive effects)

  • selegiline
  • Invega Trinza (paliperidone palmitate)
    +
    selegiline
    1 interaction

    Avoid/Use Alternative

    paliperidone + selegiline

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • selegiline transdermal
  • Invega Trinza (paliperidone palmitate)
    +
    selegiline transdermal
    1 interaction

    Avoid/Use Alternative

    paliperidone + selegiline transdermal

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • selpercatinib
  • Invega Trinza (paliperidone palmitate)
    +
    selpercatinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + selpercatinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • sertraline
  • Invega Trinza (paliperidone palmitate)
    +
    sertraline
    1 interaction

    Avoid/Use Alternative

    paliperidone + sertraline

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • sevoflurane
  • Invega Trinza (paliperidone palmitate)
    +
    sevoflurane
    1 interaction

    Avoid/Use Alternative

    paliperidone + sevoflurane

    use alternative or monitor ECG, BP, respiratory rate: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • siponimod
  • Invega Trinza (paliperidone palmitate)
    +
    siponimod
    1 interaction

    Avoid/Use Alternative

    paliperidone + siponimod

    consider alternative or monitor HR, ECG: combo may incr. risk of bradycardia, AV block, QT prolongation, cardiac arrhythmias (additive effects)

  • solifenacin
  • Invega Trinza (paliperidone palmitate)
    +
    solifenacin
    1 interaction

    Avoid/Use Alternative

    paliperidone + solifenacin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • sorafenib
  • Invega Trinza (paliperidone palmitate)
    +
    sorafenib
    1 interaction

    Avoid/Use Alternative

    paliperidone + sorafenib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • sotalol
  • Invega Trinza (paliperidone palmitate)
    +
    sotalol
    1 interaction

    Avoid/Use Alternative

    paliperidone + sotalol

    use alternative or monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope (additive effects)

  • St. John's wort
  • Invega Trinza (paliperidone palmitate)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    paliperidone + St. John's wort

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (hepatic metabolism induced; P-gp-mediated transport induced)

  • taletrectinib
  • Invega Trinza (paliperidone palmitate)
    +
    taletrectinib
    1 interaction

    Avoid/Use Alternative

    paliperidone + taletrectinib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • telavancin
  • Invega Trinza (paliperidone palmitate)
    +
    telavancin
    1 interaction

    Avoid/Use Alternative

    paliperidone + telavancin

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • tetrabenazine
  • Invega Trinza (paliperidone palmitate)
    +
    tetrabenazine
    1 interaction

    Avoid/Use Alternative

    paliperidone + tetrabenazine

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, neuroleptic malignant syndrome, extrapyramidal symptoms, CNS depression, psychomotor impairment (additive effects)

  • thalidomide
  • Invega Trinza (paliperidone palmitate)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    paliperidone + thalidomide

    use alternative or monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tipranavir
  • Invega Trinza (paliperidone palmitate)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    paliperidone + tipranavir

    IM PALIPERIDONE: use alternative; ORAL PALIPERIDONE: consider paliperidone dose adjustment: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport induced)

  • toremifene
  • Invega Trinza (paliperidone palmitate)
    +
    toremifene
    1 interaction

    Avoid/Use Alternative

    paliperidone + toremifene

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • tradipitant
  • Invega Trinza (paliperidone palmitate)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    paliperidone + tradipitant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tramadol
  • Invega Trinza (paliperidone palmitate)
    +
    tramadol
    1 interaction

    Avoid/Use Alternative

    paliperidone + tramadol

    use alternative or monitor respiratory rate, ECG, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, seizures, QT prolongation, cardiac arrhythmias, severe hypotension, including orthostasis, syncope (additive effects)

  • tranylcypromine
  • Invega Trinza (paliperidone palmitate)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    paliperidone + tranylcypromine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • trazodone
  • Invega Trinza (paliperidone palmitate)
    +
    trazodone
    1 interaction

    Avoid/Use Alternative

    paliperidone + trazodone

    use alternative or monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • triclabendazole
  • Invega Trinza (paliperidone palmitate)
    +
    triclabendazole
    1 interaction

    Avoid/Use Alternative

    paliperidone + triclabendazole

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • trifluridine
  • Invega Trinza (paliperidone palmitate)
    +
    trifluridine
    1 interaction

    Avoid/Use Alternative

    paliperidone + trifluridine

    use alternative or monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • trimethobenzamide
  • Invega Trinza (paliperidone palmitate)
    +
    trimethobenzamide
    1 interaction

    Avoid/Use Alternative

    paliperidone + trimethobenzamide

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • triptorelin
  • Invega Trinza (paliperidone palmitate)
    +
    triptorelin
    1 interaction

    Avoid/Use Alternative

    paliperidone + triptorelin

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias; may decr. triptorelin efficacy (additive effects, androgen deprivation may prolong QT; paliperidone may cause hyperprolactinemia, decr. GnRH receptors)

  • turmeric
  • Invega Trinza (paliperidone palmitate)
    +
    turmeric
    1 interaction

    Avoid/Use Alternative

    paliperidone + turmeric

    IM PALIPERIDONE: use alternative w/ oral turmeric; ORAL PALIPERIDONE: consider paliperidone dose adjustment w/ oral turmeric: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport induced)

  • vandetanib
  • Invega Trinza (paliperidone palmitate)
    +
    vandetanib
    1 interaction

    Avoid/Use Alternative

    paliperidone + vandetanib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • vemurafenib
  • Invega Trinza (paliperidone palmitate)
    +
    vemurafenib
    1 interaction

    Avoid/Use Alternative

    paliperidone + vemurafenib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • ziftomenib
  • Invega Trinza (paliperidone palmitate)
    +
    ziftomenib
    1 interaction

    Avoid/Use Alternative

    paliperidone + ziftomenib

    use alternative or monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • ziprasidone
  • Invega Trinza (paliperidone palmitate)
    +
    ziprasidone
    1 interaction

    Avoid/Use Alternative

    paliperidone + ziprasidone

    avoid combo: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, other adverse effects (additive effects, duplicate therapy)

  • zuranolone
  • Invega Trinza (paliperidone palmitate)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    paliperidone + zuranolone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

  • acarbose
  • Invega Trinza (paliperidone palmitate)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    paliperidone + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • Invega Trinza (paliperidone palmitate)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + acebutolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • albuterol
  • Invega Trinza (paliperidone palmitate)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    paliperidone + albuterol

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • albuterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + albuterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • alfentanil
  • Invega Trinza (paliperidone palmitate)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    paliperidone + alfentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Invega Trinza (paliperidone palmitate)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    paliperidone + alfuzosin

    monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Invega Trinza (paliperidone palmitate)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    paliperidone + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • alogliptin
  • Invega Trinza (paliperidone palmitate)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    paliperidone + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprazolam
  • Invega Trinza (paliperidone palmitate)
    +
    alprazolam
    1 interaction

    Monitor/Modify Tx

    paliperidone + alprazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • alprostadil intracavernous
  • Invega Trinza (paliperidone palmitate)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    paliperidone + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • amantadine
  • Invega Trinza (paliperidone palmitate)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    paliperidone + amantadine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Invega Trinza (paliperidone palmitate)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    paliperidone + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • amiloride
  • Invega Trinza (paliperidone palmitate)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    paliperidone + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amisulpride
  • Invega Trinza (paliperidone palmitate)
    +
    amisulpride
    1 interaction

    Monitor/Modify Tx

    paliperidone + amisulpride

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • amitriptyline
  • Invega Trinza (paliperidone palmitate)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    paliperidone + amitriptyline

    monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • amlodipine
  • Invega Trinza (paliperidone palmitate)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amoxapine
  • Invega Trinza (paliperidone palmitate)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    paliperidone + amoxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Invega Trinza (paliperidone palmitate)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    paliperidone + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • aprocitentan
  • Invega Trinza (paliperidone palmitate)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    paliperidone + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • arformoterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + arformoterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • articaine
  • Invega Trinza (paliperidone palmitate)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    paliperidone + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • asciminib
  • Invega Trinza (paliperidone palmitate)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    paliperidone + asciminib

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • atenolol
  • Invega Trinza (paliperidone palmitate)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • avanafil
  • Invega Trinza (paliperidone palmitate)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    paliperidone + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Invega Trinza (paliperidone palmitate)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    paliperidone + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • baclofen intrathecal
  • Invega Trinza (paliperidone palmitate)
    +
    baclofen intrathecal
    1 interaction

    Monitor/Modify Tx

    paliperidone + baclofen intrathecal

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • benazepril
  • Invega Trinza (paliperidone palmitate)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    paliperidone + benazepril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • berberine
  • Invega Trinza (paliperidone palmitate)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    paliperidone + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • berotralstat
  • Invega Trinza (paliperidone palmitate)
    +
    berotralstat
    1 interaction

    Monitor/Modify Tx

    paliperidone + berotralstat

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • betaxolol
  • Invega Trinza (paliperidone palmitate)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • betaxolol ophthalmic
  • Invega Trinza (paliperidone palmitate)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    paliperidone + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bethanechol
  • Invega Trinza (paliperidone palmitate)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    paliperidone + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bexagliflozin
  • Invega Trinza (paliperidone palmitate)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    paliperidone + bexagliflozin

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bisoprolol
  • Invega Trinza (paliperidone palmitate)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bortezomib
  • Invega Trinza (paliperidone palmitate)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    paliperidone + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brexpiprazole
  • Invega Trinza (paliperidone palmitate)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    paliperidone + brexpiprazole

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • brimonidine ophthalmic
  • Invega Trinza (paliperidone palmitate)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    paliperidone + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • brimonidine topical
  • Invega Trinza (paliperidone palmitate)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    paliperidone + brimonidine topical

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • bumetanide
  • Invega Trinza (paliperidone palmitate)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    paliperidone + bumetanide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bupivacaine
  • Invega Trinza (paliperidone palmitate)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    paliperidone + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bupivacaine liposomal
  • Invega Trinza (paliperidone palmitate)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    paliperidone + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • buprenorphine
  • Invega Trinza (paliperidone palmitate)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    paliperidone + buprenorphine

    monitor respiratory rate, ECG, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, severe hypotension, including orthostasis, syncope (additive effects)

  • bupropion
  • Invega Trinza (paliperidone palmitate)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    paliperidone + bupropion

    consider lower bupropion doses: combo may incr. risk of seizures (additive effects)

  • butorphanol
  • Invega Trinza (paliperidone palmitate)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    paliperidone + butorphanol

    monitor respiratory rate, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • canagliflozin
  • Invega Trinza (paliperidone palmitate)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    paliperidone + canagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • candesartan cilexetil
  • Invega Trinza (paliperidone palmitate)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    paliperidone + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cannabis
  • Invega Trinza (paliperidone palmitate)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    paliperidone + cannabis

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • captopril
  • Invega Trinza (paliperidone palmitate)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    paliperidone + captopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cariprazine
  • Invega Trinza (paliperidone palmitate)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + cariprazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects, duplicate therapy)

  • carteolol ophthalmic
  • Invega Trinza (paliperidone palmitate)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    paliperidone + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carvedilol
  • Invega Trinza (paliperidone palmitate)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    paliperidone + carvedilol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlordiazepoxide
  • Invega Trinza (paliperidone palmitate)
    +
    chlordiazepoxide
    1 interaction

    Monitor/Modify Tx

    paliperidone + chlordiazepoxide

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • chloroprocaine
  • Invega Trinza (paliperidone palmitate)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    paliperidone + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorothiazide
  • Invega Trinza (paliperidone palmitate)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    paliperidone + chlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorpromazine
  • Invega Trinza (paliperidone palmitate)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + chlorpromazine

    monitor ECG, BP; consider decr. dose of one or both drugs: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Invega Trinza (paliperidone palmitate)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    paliperidone + chlorthalidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cilostazol
  • Invega Trinza (paliperidone palmitate)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    paliperidone + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • clevidipine
  • Invega Trinza (paliperidone palmitate)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • clobazam
  • Invega Trinza (paliperidone palmitate)
    +
    clobazam
    1 interaction

    Monitor/Modify Tx

    paliperidone + clobazam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • clofarabine
  • Invega Trinza (paliperidone palmitate)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    paliperidone + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • clomipramine
  • Invega Trinza (paliperidone palmitate)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    paliperidone + clomipramine

    monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, seizures, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • clonazepam
  • Invega Trinza (paliperidone palmitate)
    +
    clonazepam
    1 interaction

    Monitor/Modify Tx

    paliperidone + clonazepam

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • clorazepate
  • Invega Trinza (paliperidone palmitate)
    +
    clorazepate
    1 interaction

    Monitor/Modify Tx

    paliperidone + clorazepate

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • clozapine
  • Invega Trinza (paliperidone palmitate)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    paliperidone + clozapine

    monitor ECG, BP, HR, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, seizures, hyperthermia, extrapyramidal effects (additive effects)

  • coenzyme Q-10
  • Invega Trinza (paliperidone palmitate)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    paliperidone + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • colesevelam
  • Invega Trinza (paliperidone palmitate)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    paliperidone + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dapagliflozin
  • Invega Trinza (paliperidone palmitate)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    paliperidone + dapagliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • daridorexant
  • Invega Trinza (paliperidone palmitate)
    +
    daridorexant
    1 interaction

    Monitor/Modify Tx

    paliperidone + daridorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dasatinib
  • Invega Trinza (paliperidone palmitate)
    +
    dasatinib
    1 interaction

    Monitor/Modify Tx

    paliperidone + dasatinib

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • denileukin diftitox
  • Invega Trinza (paliperidone palmitate)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    paliperidone + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • deutetrabenazine
  • Invega Trinza (paliperidone palmitate)
    +
    deutetrabenazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + deutetrabenazine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, neuroleptic malignant syndrome, extrapyramidal symptoms, CNS depression, psychomotor impairment (additive effects)

  • dihydrocodeine
  • Invega Trinza (paliperidone palmitate)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    paliperidone + dihydrocodeine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Invega Trinza (paliperidone palmitate)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    paliperidone + diltiazem

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dinutuximab
  • Invega Trinza (paliperidone palmitate)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    paliperidone + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • dipyridamole
  • Invega Trinza (paliperidone palmitate)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    paliperidone + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • doxazosin
  • Invega Trinza (paliperidone palmitate)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    paliperidone + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Invega Trinza (paliperidone palmitate)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    paliperidone + doxepin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • dronabinol
  • Invega Trinza (paliperidone palmitate)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    paliperidone + dronabinol

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • dulaglutide
  • Invega Trinza (paliperidone palmitate)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    paliperidone + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Invega Trinza (paliperidone palmitate)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    paliperidone + duloxetine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • eliglustat
  • Invega Trinza (paliperidone palmitate)
    +
    eliglustat
    1 interaction

    Monitor/Modify Tx

    paliperidone + eliglustat

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • empagliflozin
  • Invega Trinza (paliperidone palmitate)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    paliperidone + empagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • enalapril
  • Invega Trinza (paliperidone palmitate)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    paliperidone + enalapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • enalaprilat
  • Invega Trinza (paliperidone palmitate)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    paliperidone + enalaprilat

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entacapone
  • Invega Trinza (paliperidone palmitate)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    paliperidone + entacapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • eplerenone
  • Invega Trinza (paliperidone palmitate)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    paliperidone + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • epoprostenol
  • Invega Trinza (paliperidone palmitate)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    paliperidone + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ertugliflozin
  • Invega Trinza (paliperidone palmitate)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    paliperidone + ertugliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • escitalopram
  • Invega Trinza (paliperidone palmitate)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    paliperidone + escitalopram

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • esketamine
  • Invega Trinza (paliperidone palmitate)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    paliperidone + esketamine

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • esmolol
  • Invega Trinza (paliperidone palmitate)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • estazolam
  • Invega Trinza (paliperidone palmitate)
    +
    estazolam
    1 interaction

    Monitor/Modify Tx

    paliperidone + estazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • eszopiclone
  • Invega Trinza (paliperidone palmitate)
    +
    eszopiclone
    1 interaction

    Monitor/Modify Tx

    paliperidone + eszopiclone

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ethacrynic acid
  • Invega Trinza (paliperidone palmitate)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    paliperidone + ethacrynic acid

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ethanol (in some formulations)
  • Invega Trinza (paliperidone palmitate)
    +
    ethanol (in some formulations)
    1 interaction

    Monitor/Modify Tx

    paliperidone + ethanol (in some formulations)

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etomidate
  • Invega Trinza (paliperidone palmitate)
    +
    etomidate
    1 interaction

    Monitor/Modify Tx

    paliperidone + etomidate

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etripamil nasal
  • Invega Trinza (paliperidone palmitate)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    paliperidone + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • exenatide
  • Invega Trinza (paliperidone palmitate)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    paliperidone + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • felodipine
  • Invega Trinza (paliperidone palmitate)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fenoldopam
  • Invega Trinza (paliperidone palmitate)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    paliperidone + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fentanyl
  • Invega Trinza (paliperidone palmitate)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    paliperidone + fentanyl

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Invega Trinza (paliperidone palmitate)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    paliperidone + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fingolimod
  • Invega Trinza (paliperidone palmitate)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    paliperidone + fingolimod

    monitor ECG overnight during fingolimod initiation/titration: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • flaxseed
  • Invega Trinza (paliperidone palmitate)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    paliperidone + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • flibanserin
  • Invega Trinza (paliperidone palmitate)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    paliperidone + flibanserin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • fluconazole
  • Invega Trinza (paliperidone palmitate)
    +
    fluconazole
    1 interaction

    Monitor/Modify Tx

    paliperidone + fluconazole

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • fluphenazine
  • Invega Trinza (paliperidone palmitate)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + fluphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • flurazepam
  • Invega Trinza (paliperidone palmitate)
    +
    flurazepam
    1 interaction

    Monitor/Modify Tx

    paliperidone + flurazepam

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • formoterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + formoterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • fosinopril
  • Invega Trinza (paliperidone palmitate)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    paliperidone + fosinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • foslevodopa
  • Invega Trinza (paliperidone palmitate)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    paliperidone + foslevodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • fostemsavir
  • Invega Trinza (paliperidone palmitate)
    +
    fostemsavir
    1 interaction

    Monitor/Modify Tx

    paliperidone + fostemsavir

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • furosemide
  • Invega Trinza (paliperidone palmitate)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    paliperidone + furosemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • gabapentin
  • Invega Trinza (paliperidone palmitate)
    +
    gabapentin
    1 interaction

    Monitor/Modify Tx

    paliperidone + gabapentin

    monitor respiratory rate; consider decreasing gabapentin dose: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decrease seizure threshold)

  • gabapentin enacarbil
  • Invega Trinza (paliperidone palmitate)
    +
    gabapentin enacarbil
    1 interaction

    Monitor/Modify Tx

    paliperidone + gabapentin enacarbil

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • garlic
  • Invega Trinza (paliperidone palmitate)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    paliperidone + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • gemtuzumab ozogamicin
  • Invega Trinza (paliperidone palmitate)
    +
    gemtuzumab ozogamicin
    1 interaction

    Monitor/Modify Tx

    paliperidone + gemtuzumab ozogamicin

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • gepirone
  • Invega Trinza (paliperidone palmitate)
    +
    gepirone
    1 interaction

    Monitor/Modify Tx

    paliperidone + gepirone

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • glimepiride
  • Invega Trinza (paliperidone palmitate)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    paliperidone + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Invega Trinza (paliperidone palmitate)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    paliperidone + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Invega Trinza (paliperidone palmitate)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    paliperidone + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • granisetron
  • Invega Trinza (paliperidone palmitate)
    +
    granisetron
    1 interaction

    Monitor/Modify Tx

    paliperidone + granisetron

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • guanfacine
  • Invega Trinza (paliperidone palmitate)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    paliperidone + guanfacine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • hydralazine
  • Invega Trinza (paliperidone palmitate)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + hydralazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • hydrochlorothiazide
  • Invega Trinza (paliperidone palmitate)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    paliperidone + hydrochlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • hydromorphone
  • Invega Trinza (paliperidone palmitate)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    paliperidone + hydromorphone

    monitor respiratory rate, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ifosfamide
  • Invega Trinza (paliperidone palmitate)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    paliperidone + ifosfamide

    D/C one or both drugs if encephalopathy occurs; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • iloprost
  • Invega Trinza (paliperidone palmitate)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    paliperidone + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • imipramine
  • Invega Trinza (paliperidone palmitate)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    paliperidone + imipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia (additive effects)

  • indapamide
  • Invega Trinza (paliperidone palmitate)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    paliperidone + indapamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • insulin
  • Invega Trinza (paliperidone palmitate)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    paliperidone + insulin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • iohexol
  • Invega Trinza (paliperidone palmitate)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    paliperidone + iohexol

    if intrathecal iohexol use, D/C paliperidone at least 48h before myelography, may resume at least 24h after procedure: combo may incr. risk of seizures (additive effects)

  • iopamidol
  • Invega Trinza (paliperidone palmitate)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    paliperidone + iopamidol

    caution advised if intrathecal iopamidol use; consider holding paliperidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • irbesartan
  • Invega Trinza (paliperidone palmitate)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    paliperidone + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iron sucrose
  • Invega Trinza (paliperidone palmitate)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    paliperidone + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • isosorbide dinitrate
  • Invega Trinza (paliperidone palmitate)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    paliperidone + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Invega Trinza (paliperidone palmitate)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    paliperidone + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isradipine
  • Invega Trinza (paliperidone palmitate)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ketamine
  • Invega Trinza (paliperidone palmitate)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    paliperidone + ketamine

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment (additive effects)

  • labetalol
  • Invega Trinza (paliperidone palmitate)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    paliperidone + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • landiolol
  • Invega Trinza (paliperidone palmitate)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lapatinib
  • Invega Trinza (paliperidone palmitate)
    +
    lapatinib
    1 interaction

    Monitor/Modify Tx

    paliperidone + lapatinib

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • lemborexant
  • Invega Trinza (paliperidone palmitate)
    +
    lemborexant
    1 interaction

    Monitor/Modify Tx

    paliperidone + lemborexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lenvatinib
  • Invega Trinza (paliperidone palmitate)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    paliperidone + lenvatinib

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • levalbuterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + levalbuterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • levobunolol ophthalmic
  • Invega Trinza (paliperidone palmitate)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    paliperidone + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levodopa
  • Invega Trinza (paliperidone palmitate)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    paliperidone + levodopa

    monitor BP: combo may decr. efficacy of both drugs; may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • levorphanol
  • Invega Trinza (paliperidone palmitate)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    paliperidone + levorphanol

    monitor respiratory rate, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • lidocaine
  • Invega Trinza (paliperidone palmitate)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    paliperidone + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • linagliptin
  • Invega Trinza (paliperidone palmitate)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    paliperidone + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liraglutide
  • Invega Trinza (paliperidone palmitate)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    paliperidone + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisinopril
  • Invega Trinza (paliperidone palmitate)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    paliperidone + lisinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lithium
  • Invega Trinza (paliperidone palmitate)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    paliperidone + lithium

    D/C one or both drugs if encephalopathy occurs: combo may incr. risk of encephalopathic syndrome, extrapyramidal symptoms (additive effects)

  • lixisenatide
  • Invega Trinza (paliperidone palmitate)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    paliperidone + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorazepam
  • Invega Trinza (paliperidone palmitate)
    +
    lorazepam
    1 interaction

    Monitor/Modify Tx

    paliperidone + lorazepam

    monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • losartan
  • Invega Trinza (paliperidone palmitate)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    paliperidone + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • loxapine
  • Invega Trinza (paliperidone palmitate)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    paliperidone + loxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), extrapyramidal symptoms, hyperthermia (additive effects)

  • lubiprostone
  • Invega Trinza (paliperidone palmitate)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    paliperidone + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • magnesium sulfate
  • Invega Trinza (paliperidone palmitate)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    paliperidone + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • maraviroc
  • Invega Trinza (paliperidone palmitate)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    paliperidone + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mavorixafor
  • Invega Trinza (paliperidone palmitate)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    paliperidone + mavorixafor

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • mefloquine
  • Invega Trinza (paliperidone palmitate)
    +
    mefloquine
    1 interaction

    Monitor/Modify Tx

    paliperidone + mefloquine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • meperidine
  • Invega Trinza (paliperidone palmitate)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    paliperidone + meperidine

    monitor respiratory rate, ECG, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, QT prolongation, cardiac arrhythmias, severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Invega Trinza (paliperidone palmitate)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    paliperidone + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metformin
  • Invega Trinza (paliperidone palmitate)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    paliperidone + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methohexital
  • Invega Trinza (paliperidone palmitate)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    paliperidone + methohexital

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • methyldopa
  • Invega Trinza (paliperidone palmitate)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    paliperidone + methyldopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • methylene blue injection
  • Invega Trinza (paliperidone palmitate)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    paliperidone + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metolazone
  • Invega Trinza (paliperidone palmitate)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    paliperidone + metolazone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metoprolol
  • Invega Trinza (paliperidone palmitate)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metronidazole
  • Invega Trinza (paliperidone palmitate)
    +
    metronidazole
    1 interaction

    Monitor/Modify Tx

    paliperidone + metronidazole

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • midostaurin
  • Invega Trinza (paliperidone palmitate)
    +
    midostaurin
    1 interaction

    Monitor/Modify Tx

    paliperidone + midostaurin

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • miglitol
  • Invega Trinza (paliperidone palmitate)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    paliperidone + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milrinone
  • Invega Trinza (paliperidone palmitate)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    paliperidone + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • minoxidil
  • Invega Trinza (paliperidone palmitate)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    paliperidone + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mirtazapine
  • Invega Trinza (paliperidone palmitate)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    paliperidone + mirtazapine

    monitor ECG, BP; consider decr. dose of one or both drugs: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • moexipril
  • Invega Trinza (paliperidone palmitate)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    paliperidone + moexipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • molindone
  • Invega Trinza (paliperidone palmitate)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    paliperidone + molindone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • morphine
  • Invega Trinza (paliperidone palmitate)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    paliperidone + morphine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nadolol
  • Invega Trinza (paliperidone palmitate)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + nadolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nalbuphine
  • Invega Trinza (paliperidone palmitate)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    paliperidone + nalbuphine

    monitor respiratory rate, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Invega Trinza (paliperidone palmitate)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    paliperidone + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Invega Trinza (paliperidone palmitate)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    paliperidone + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • naxitamab
  • Invega Trinza (paliperidone palmitate)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    paliperidone + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nebivolol
  • Invega Trinza (paliperidone palmitate)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nelarabine
  • Invega Trinza (paliperidone palmitate)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    paliperidone + nelarabine

    withhold nelarabine if Grade 2 or greater somnolence occurs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • niacin (vitamin B3)
  • Invega Trinza (paliperidone palmitate)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    paliperidone + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nicardipine
  • Invega Trinza (paliperidone palmitate)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nifedipine
  • Invega Trinza (paliperidone palmitate)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nimodipine
  • Invega Trinza (paliperidone palmitate)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nisoldipine
  • Invega Trinza (paliperidone palmitate)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    paliperidone + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nitric oxide
  • Invega Trinza (paliperidone palmitate)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    paliperidone + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nitrite
  • Invega Trinza (paliperidone palmitate)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    paliperidone + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Invega Trinza (paliperidone palmitate)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    paliperidone + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Invega Trinza (paliperidone palmitate)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    paliperidone + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nortriptyline
  • Invega Trinza (paliperidone palmitate)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    paliperidone + nortriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • obinutuzumab
  • Invega Trinza (paliperidone palmitate)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    paliperidone + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ofloxacin
  • Invega Trinza (paliperidone palmitate)
    +
    ofloxacin
    1 interaction

    Monitor/Modify Tx

    paliperidone + ofloxacin

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • olmesartan medoxomil
  • Invega Trinza (paliperidone palmitate)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    paliperidone + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • olodaterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + olodaterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • opicapone
  • Invega Trinza (paliperidone palmitate)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    paliperidone + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Invega Trinza (paliperidone palmitate)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    paliperidone + opium

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • osilodrostat
  • Invega Trinza (paliperidone palmitate)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    paliperidone + osilodrostat

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • oxazepam
  • Invega Trinza (paliperidone palmitate)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    paliperidone + oxazepam

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • oxybutynin
  • Invega Trinza (paliperidone palmitate)
    +
    oxybutynin
    1 interaction

    Monitor/Modify Tx

    paliperidone + oxybutynin

    decr. dose of one or both drugs or consider oxybutynin transdermal patch: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; somnolence less likely with oxybutynin transdermal patch (additive effects)

  • oxycodone
  • Invega Trinza (paliperidone palmitate)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    paliperidone + oxycodone

    monitor respiratory rate, BP; decr. oxycodone start dose by at least 50%, consider decr. paliperidone dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Invega Trinza (paliperidone palmitate)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    paliperidone + oxymorphone

    monitor respiratory rate, BP; decr. oxymorphone start dose by at least 50%, consider decr. paliperidone dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Invega Trinza (paliperidone palmitate)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    paliperidone + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pentazocine
  • Invega Trinza (paliperidone palmitate)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    paliperidone + pentazocine

    monitor respiratory rate, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • perindopril
  • Invega Trinza (paliperidone palmitate)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    paliperidone + perindopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • perphenazine
  • Invega Trinza (paliperidone palmitate)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + perphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, severe hypotension, including orthostasis, syncope (additive effects)

  • phenoxybenzamine
  • Invega Trinza (paliperidone palmitate)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    paliperidone + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • phentolamine
  • Invega Trinza (paliperidone palmitate)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    paliperidone + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pindolol
  • Invega Trinza (paliperidone palmitate)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + pindolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pioglitazone
  • Invega Trinza (paliperidone palmitate)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    paliperidone + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • posaconazole
  • Invega Trinza (paliperidone palmitate)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    paliperidone + posaconazole

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pralsetinib
  • Invega Trinza (paliperidone palmitate)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    paliperidone + pralsetinib

    monitor ECG; consider monitoring electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • pramipexole
  • Invega Trinza (paliperidone palmitate)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    paliperidone + pramipexole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • pramlintide
  • Invega Trinza (paliperidone palmitate)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    paliperidone + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Invega Trinza (paliperidone palmitate)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    paliperidone + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pregabalin
  • Invega Trinza (paliperidone palmitate)
    +
    pregabalin
    1 interaction

    Monitor/Modify Tx

    paliperidone + pregabalin

    monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • primaquine
  • Invega Trinza (paliperidone palmitate)
    +
    primaquine
    1 interaction

    Monitor/Modify Tx

    paliperidone + primaquine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • procarbazine
  • Invega Trinza (paliperidone palmitate)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + procarbazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • prochlorperazine
  • Invega Trinza (paliperidone palmitate)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + prochlorperazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), extrapyramidal symptoms, hyperthermia (additive effects)

  • propofol
  • Invega Trinza (paliperidone palmitate)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    paliperidone + propofol

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • propranolol
  • Invega Trinza (paliperidone palmitate)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • protriptyline
  • Invega Trinza (paliperidone palmitate)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    paliperidone + protriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • quazepam
  • Invega Trinza (paliperidone palmitate)
    +
    quazepam
    1 interaction

    Monitor/Modify Tx

    paliperidone + quazepam

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • quinapril
  • Invega Trinza (paliperidone palmitate)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    paliperidone + quinapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ramipril
  • Invega Trinza (paliperidone palmitate)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    paliperidone + ramipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ranolazine
  • Invega Trinza (paliperidone palmitate)
    +
    ranolazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + ranolazine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • relugolix
  • Invega Trinza (paliperidone palmitate)
    +
    relugolix
    1 interaction

    Monitor/Modify Tx

    paliperidone + relugolix

    if prostate cancer use, monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects, androgen deprivation may prolong QT)

  • remifentanil
  • Invega Trinza (paliperidone palmitate)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    paliperidone + remifentanil

    monitor respiratory rate, BP, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Invega Trinza (paliperidone palmitate)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    paliperidone + remimazolam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of hypotension (including orthostasis, syncope), profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • repaglinide
  • Invega Trinza (paliperidone palmitate)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    paliperidone + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • riociguat
  • Invega Trinza (paliperidone palmitate)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    paliperidone + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • risperidone
  • Invega Trinza (paliperidone palmitate)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    paliperidone + risperidone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • ropinirole
  • Invega Trinza (paliperidone palmitate)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    paliperidone + ropinirole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • ropivacaine
  • Invega Trinza (paliperidone palmitate)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    paliperidone + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • rosiglitazone
  • Invega Trinza (paliperidone palmitate)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    paliperidone + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Invega Trinza (paliperidone palmitate)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    paliperidone + rotigotine transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • sacituzumab govitecan
  • Invega Trinza (paliperidone palmitate)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    paliperidone + sacituzumab govitecan

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • sacubitril
  • Invega Trinza (paliperidone palmitate)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    paliperidone + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • salmeterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + salmeterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • saxagliptin
  • Invega Trinza (paliperidone palmitate)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    paliperidone + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sebetralstat
  • Invega Trinza (paliperidone palmitate)
    +
    sebetralstat
    1 interaction

    Monitor/Modify Tx

    paliperidone + sebetralstat

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • semaglutide
  • Invega Trinza (paliperidone palmitate)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    paliperidone + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sildenafil
  • Invega Trinza (paliperidone palmitate)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    paliperidone + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • silodosin
  • Invega Trinza (paliperidone palmitate)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    paliperidone + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sitagliptin
  • Invega Trinza (paliperidone palmitate)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    paliperidone + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium ferric gluconate complex
  • Invega Trinza (paliperidone palmitate)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    paliperidone + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sotagliflozin
  • Invega Trinza (paliperidone palmitate)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    paliperidone + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sparsentan
  • Invega Trinza (paliperidone palmitate)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    paliperidone + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Invega Trinza (paliperidone palmitate)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    paliperidone + spironolactone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sufentanil
  • Invega Trinza (paliperidone palmitate)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    paliperidone + sufentanil

    monitor respiratory rate, BP, decr. sufentanil start dose, consider decr. paliperidone dose, use lowest effective doses: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • sunitinib
  • Invega Trinza (paliperidone palmitate)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    paliperidone + sunitinib

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • suvorexant
  • Invega Trinza (paliperidone palmitate)
    +
    suvorexant
    1 interaction

    Monitor/Modify Tx

    paliperidone + suvorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tacrolimus
  • Invega Trinza (paliperidone palmitate)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    paliperidone + tacrolimus

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • tadalafil
  • Invega Trinza (paliperidone palmitate)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    paliperidone + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tagraxofusp
  • Invega Trinza (paliperidone palmitate)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    paliperidone + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tamsulosin
  • Invega Trinza (paliperidone palmitate)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    paliperidone + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Invega Trinza (paliperidone palmitate)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    paliperidone + tapentadol

    monitor respiratory rate, BP; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Invega Trinza (paliperidone palmitate)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    paliperidone + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tazemetostat
  • Invega Trinza (paliperidone palmitate)
    +
    tazemetostat
    1 interaction

    Monitor/Modify Tx

    paliperidone + tazemetostat

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • telmisartan
  • Invega Trinza (paliperidone palmitate)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    paliperidone + telmisartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • temazepam
  • Invega Trinza (paliperidone palmitate)
    +
    temazepam
    1 interaction

    Monitor/Modify Tx

    paliperidone + temazepam

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • terazosin
  • Invega Trinza (paliperidone palmitate)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    paliperidone + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbutaline
  • Invega Trinza (paliperidone palmitate)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    paliperidone + terbutaline

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • thiothixene
  • Invega Trinza (paliperidone palmitate)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    paliperidone + thiothixene

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), extrapyramidal symptoms, hyperthermia (additive effects)

  • timolol
  • Invega Trinza (paliperidone palmitate)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    paliperidone + timolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • timolol ophthalmic
  • Invega Trinza (paliperidone palmitate)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    paliperidone + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tirzepatide
  • Invega Trinza (paliperidone palmitate)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    paliperidone + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Invega Trinza (paliperidone palmitate)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    paliperidone + tizanidine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Invega Trinza (paliperidone palmitate)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    paliperidone + tolcapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tolterodine
  • Invega Trinza (paliperidone palmitate)
    +
    tolterodine
    1 interaction

    Monitor/Modify Tx

    paliperidone + tolterodine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • torsemide
  • Invega Trinza (paliperidone palmitate)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    paliperidone + torsemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Invega Trinza (paliperidone palmitate)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    paliperidone + trandolapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Invega Trinza (paliperidone palmitate)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    paliperidone + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • triamterene
  • Invega Trinza (paliperidone palmitate)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    paliperidone + triamterene

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • triazolam
  • Invega Trinza (paliperidone palmitate)
    +
    triazolam
    1 interaction

    Monitor/Modify Tx

    paliperidone + triazolam

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • trifluoperazine
  • Invega Trinza (paliperidone palmitate)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + trifluoperazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, severe hypotension, including orthostasis, syncope (additive effects)

  • trimipramine
  • Invega Trinza (paliperidone palmitate)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    paliperidone + trimipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • valbenazine
  • Invega Trinza (paliperidone palmitate)
    +
    valbenazine
    1 interaction

    Monitor/Modify Tx

    paliperidone + valbenazine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • valsartan
  • Invega Trinza (paliperidone palmitate)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    paliperidone + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • vardenafil
  • Invega Trinza (paliperidone palmitate)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    paliperidone + vardenafil

    monitor ECG, BP: combo may incr. risk of QT prolongation, cardiac arrhythmias, hypotension, including orthostasis, syncope (additive effects)

  • venlafaxine
  • Invega Trinza (paliperidone palmitate)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    paliperidone + venlafaxine

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias, CNS depression, psychomotor impairment (additive effects)

  • verapamil
  • Invega Trinza (paliperidone palmitate)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    paliperidone + verapamil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • vilanterol inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    paliperidone + vilanterol inhaled

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • voclosporin
  • Invega Trinza (paliperidone palmitate)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    paliperidone + voclosporin

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • voriconazole
  • Invega Trinza (paliperidone palmitate)
    +
    voriconazole
    1 interaction

    Monitor/Modify Tx

    paliperidone + voriconazole

    monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

  • vosoritide
  • Invega Trinza (paliperidone palmitate)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    paliperidone + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • yohimbe
  • Invega Trinza (paliperidone palmitate)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    paliperidone + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • zaleplon
  • Invega Trinza (paliperidone palmitate)
    +
    zaleplon
    1 interaction

    Monitor/Modify Tx

    paliperidone + zaleplon

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Invega Trinza (paliperidone palmitate)
    +
    ziconotide
    1 interaction

    Monitor/Modify Tx

    paliperidone + ziconotide

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolpidem
  • Invega Trinza (paliperidone palmitate)
    +
    zolpidem
    1 interaction

    Monitor/Modify Tx

    paliperidone + zolpidem

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Caution Advised

  • 5-HTP
  • Invega Trinza (paliperidone palmitate)
    +
    5-HTP
    1 interaction

    Caution Advised

    paliperidone + 5-HTP

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • acetazolamide
  • Invega Trinza (paliperidone palmitate)
    +
    acetazolamide
    1 interaction

    Caution Advised

    paliperidone + acetazolamide

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, paliperidone may decr. seizure threshold)

  • aclidinium inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    paliperidone + aclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • allopurinol
  • Invega Trinza (paliperidone palmitate)
    +
    allopurinol
    1 interaction

    Caution Advised

    paliperidone + allopurinol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • almotriptan
  • Invega Trinza (paliperidone palmitate)
    +
    almotriptan
    1 interaction

    Caution Advised

    paliperidone + almotriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • atropine
  • Invega Trinza (paliperidone palmitate)
    +
    atropine
    1 interaction

    Caution Advised

    paliperidone + atropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • baclofen
  • Invega Trinza (paliperidone palmitate)
    +
    baclofen
    1 interaction

    Caution Advised

    paliperidone + baclofen

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • belladonna alkaloids
  • Invega Trinza (paliperidone palmitate)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    paliperidone + belladonna alkaloids

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • botulinum toxin
  • Invega Trinza (paliperidone palmitate)
    +
    botulinum toxin
    1 interaction

    Caution Advised

    paliperidone + botulinum toxin

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • brivaracetam
  • Invega Trinza (paliperidone palmitate)
    +
    brivaracetam
    1 interaction

    Caution Advised

    paliperidone + brivaracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • brompheniramine
  • Invega Trinza (paliperidone palmitate)
    +
    brompheniramine
    1 interaction

    Caution Advised

    paliperidone + brompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • buspirone
  • Invega Trinza (paliperidone palmitate)
    +
    buspirone
    1 interaction

    Caution Advised

    paliperidone + buspirone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • busulfan
  • Invega Trinza (paliperidone palmitate)
    +
    busulfan
    1 interaction

    Caution Advised

    paliperidone + busulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • cannabidiol
  • Invega Trinza (paliperidone palmitate)
    +
    cannabidiol
    1 interaction

    Caution Advised

    paliperidone + cannabidiol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • carbinoxamine
  • Invega Trinza (paliperidone palmitate)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    paliperidone + carbinoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • carisoprodol
  • Invega Trinza (paliperidone palmitate)
    +
    carisoprodol
    1 interaction

    Caution Advised

    paliperidone + carisoprodol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cenobamate
  • Invega Trinza (paliperidone palmitate)
    +
    cenobamate
    1 interaction

    Caution Advised

    paliperidone + cenobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • cetirizine
  • Invega Trinza (paliperidone palmitate)
    +
    cetirizine
    1 interaction

    Caution Advised

    paliperidone + cetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chamomile, German
  • Invega Trinza (paliperidone palmitate)
    +
    chamomile, German
    1 interaction

    Caution Advised

    paliperidone + chamomile, German

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chasteberry
  • Invega Trinza (paliperidone palmitate)
    +
    chasteberry
    1 interaction

    Caution Advised

    paliperidone + chasteberry

    caution advised: combo may decr. paliperidone efficacy (antagonistic effects, chasteberry exerts dopaminergic effects)

  • chlophedianol
  • Invega Trinza (paliperidone palmitate)
    +
    chlophedianol
    1 interaction

    Caution Advised

    paliperidone + chlophedianol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorambucil
  • Invega Trinza (paliperidone palmitate)
    +
    chlorambucil
    1 interaction

    Caution Advised

    paliperidone + chlorambucil

    caution advised: combo may incr. risk of seizures (additive effects)

  • chlorcyclizine
  • Invega Trinza (paliperidone palmitate)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    paliperidone + chlorcyclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorpheniramine
  • Invega Trinza (paliperidone palmitate)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    paliperidone + chlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorzoxazone
  • Invega Trinza (paliperidone palmitate)
    +
    chlorzoxazone
    1 interaction

    Caution Advised

    paliperidone + chlorzoxazone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may incr. anticholinergic effects with some combos (additive effects)

  • clemastine
  • Invega Trinza (paliperidone palmitate)
    +
    clemastine
    1 interaction

    Caution Advised

    paliperidone + clemastine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • clidinium
  • Invega Trinza (paliperidone palmitate)
    +
    clidinium
    1 interaction

    Caution Advised

    paliperidone + clidinium

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • cyclobenzaprine
  • Invega Trinza (paliperidone palmitate)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    paliperidone + cyclobenzaprine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • cyproheptadine
  • Invega Trinza (paliperidone palmitate)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    paliperidone + cyproheptadine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dantrolene
  • Invega Trinza (paliperidone palmitate)
    +
    dantrolene
    1 interaction

    Caution Advised

    paliperidone + dantrolene

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Invega Trinza (paliperidone palmitate)
    +
    darifenacin
    1 interaction

    Caution Advised

    paliperidone + darifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • desvenlafaxine
  • Invega Trinza (paliperidone palmitate)
    +
    desvenlafaxine
    1 interaction

    Caution Advised

    paliperidone + desvenlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dexbrompheniramine
  • Invega Trinza (paliperidone palmitate)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    paliperidone + dexbrompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dexchlorpheniramine
  • Invega Trinza (paliperidone palmitate)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    paliperidone + dexchlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dichlorphenamide
  • Invega Trinza (paliperidone palmitate)
    +
    dichlorphenamide
    1 interaction

    Caution Advised

    paliperidone + dichlorphenamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dicyclomine
  • Invega Trinza (paliperidone palmitate)
    +
    dicyclomine
    1 interaction

    Caution Advised

    paliperidone + dicyclomine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • difelikefalin
  • Invega Trinza (paliperidone palmitate)
    +
    difelikefalin
    1 interaction

    Caution Advised

    paliperidone + difelikefalin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Invega Trinza (paliperidone palmitate)
    +
    difenoxin
    1 interaction

    Caution Advised

    paliperidone + difenoxin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dimenhydrinate
  • Invega Trinza (paliperidone palmitate)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    paliperidone + dimenhydrinate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenhydramine
  • Invega Trinza (paliperidone palmitate)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    paliperidone + diphenhydramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenoxylate
  • Invega Trinza (paliperidone palmitate)
    +
    diphenoxylate
    1 interaction

    Caution Advised

    paliperidone + diphenoxylate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • doxepin topical
  • Invega Trinza (paliperidone palmitate)
    +
    doxepin topical
    1 interaction

    Caution Advised

    paliperidone + doxepin topical

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • eletriptan
  • Invega Trinza (paliperidone palmitate)
    +
    eletriptan
    1 interaction

    Caution Advised

    paliperidone + eletriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Invega Trinza (paliperidone palmitate)
    +
    elinzanetant
    1 interaction

    Caution Advised

    paliperidone + elinzanetant

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • eslicarbazepine acetate
  • Invega Trinza (paliperidone palmitate)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    paliperidone + eslicarbazepine acetate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • ethosuximide
  • Invega Trinza (paliperidone palmitate)
    +
    ethosuximide
    1 interaction

    Caution Advised

    paliperidone + ethosuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • felbamate
  • Invega Trinza (paliperidone palmitate)
    +
    felbamate
    1 interaction

    Caution Advised

    paliperidone + felbamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • fenfluramine
  • Invega Trinza (paliperidone palmitate)
    +
    fenfluramine
    1 interaction

    Caution Advised

    paliperidone + fenfluramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • fesoterodine
  • Invega Trinza (paliperidone palmitate)
    +
    fesoterodine
    1 interaction

    Caution Advised

    paliperidone + fesoterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • flavoxate
  • Invega Trinza (paliperidone palmitate)
    +
    flavoxate
    1 interaction

    Caution Advised

    paliperidone + flavoxate

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • fluvoxamine
  • Invega Trinza (paliperidone palmitate)
    +
    fluvoxamine
    1 interaction

    Caution Advised

    paliperidone + fluvoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • frovatriptan
  • Invega Trinza (paliperidone palmitate)
    +
    frovatriptan
    1 interaction

    Caution Advised

    paliperidone + frovatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • galantamine
  • Invega Trinza (paliperidone palmitate)
    +
    galantamine
    1 interaction

    Caution Advised

    paliperidone + galantamine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • ganaxolone
  • Invega Trinza (paliperidone palmitate)
    +
    ganaxolone
    1 interaction

    Caution Advised

    paliperidone + ganaxolone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • glofitamab
  • Invega Trinza (paliperidone palmitate)
    +
    glofitamab
    1 interaction

    Caution Advised

    paliperidone + glofitamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate
  • Invega Trinza (paliperidone palmitate)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    paliperidone + glycopyrrolate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • glycopyrrolate inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    paliperidone + glycopyrrolate inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • glycopyrronium topical
  • Invega Trinza (paliperidone palmitate)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    paliperidone + glycopyrronium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • homatropine
  • Invega Trinza (paliperidone palmitate)
    +
    homatropine
    1 interaction

    Caution Advised

    paliperidone + homatropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • hyoscyamine
  • Invega Trinza (paliperidone palmitate)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    paliperidone + hyoscyamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ipratropium inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    paliperidone + ipratropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • lacosamide
  • Invega Trinza (paliperidone palmitate)
    +
    lacosamide
    1 interaction

    Caution Advised

    paliperidone + lacosamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • lamotrigine
  • Invega Trinza (paliperidone palmitate)
    +
    lamotrigine
    1 interaction

    Caution Advised

    paliperidone + lamotrigine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • levetiracetam
  • Invega Trinza (paliperidone palmitate)
    +
    levetiracetam
    1 interaction

    Caution Advised

    paliperidone + levetiracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • levocetirizine
  • Invega Trinza (paliperidone palmitate)
    +
    levocetirizine
    1 interaction

    Caution Advised

    paliperidone + levocetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levomilnacipran
  • Invega Trinza (paliperidone palmitate)
    +
    levomilnacipran
    1 interaction

    Caution Advised

    paliperidone + levomilnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • linvoseltamab
  • Invega Trinza (paliperidone palmitate)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    paliperidone + linvoseltamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • magnesium citrate
  • Invega Trinza (paliperidone palmitate)
    +
    magnesium citrate
    1 interaction

    Caution Advised

    paliperidone + magnesium citrate

    caution advised, especially if magnesium citrate bowel prep use: combo may incr. risk of seizures (additive effects)

  • meclizine
  • Invega Trinza (paliperidone palmitate)
    +
    meclizine
    1 interaction

    Caution Advised

    paliperidone + meclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • melatonin
  • Invega Trinza (paliperidone palmitate)
    +
    melatonin
    1 interaction

    Caution Advised

    paliperidone + melatonin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meprobamate
  • Invega Trinza (paliperidone palmitate)
    +
    meprobamate
    1 interaction

    Caution Advised

    paliperidone + meprobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meropenem
  • Invega Trinza (paliperidone palmitate)
    +
    meropenem
    1 interaction

    Caution Advised

    paliperidone + meropenem

    caution advised: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport possibly induced)

  • methocarbamol
  • Invega Trinza (paliperidone palmitate)
    +
    methocarbamol
    1 interaction

    Caution Advised

    paliperidone + methocarbamol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methscopolamine
  • Invega Trinza (paliperidone palmitate)
    +
    methscopolamine
    1 interaction

    Caution Advised

    paliperidone + methscopolamine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • methsuximide
  • Invega Trinza (paliperidone palmitate)
    +
    methsuximide
    1 interaction

    Caution Advised

    paliperidone + methsuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • metyrapone
  • Invega Trinza (paliperidone palmitate)
    +
    metyrapone
    1 interaction

    Caution Advised

    paliperidone + metyrapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Invega Trinza (paliperidone palmitate)
    +
    metyrosine
    1 interaction

    Caution Advised

    paliperidone + metyrosine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • milnacipran
  • Invega Trinza (paliperidone palmitate)
    +
    milnacipran
    1 interaction

    Caution Advised

    paliperidone + milnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mosunetuzumab
  • Invega Trinza (paliperidone palmitate)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    paliperidone + mosunetuzumab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Invega Trinza (paliperidone palmitate)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    paliperidone + mycophenolate mofetil

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naltrexone
  • Invega Trinza (paliperidone palmitate)
    +
    naltrexone
    1 interaction

    Caution Advised

    paliperidone + naltrexone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naratriptan
  • Invega Trinza (paliperidone palmitate)
    +
    naratriptan
    1 interaction

    Caution Advised

    paliperidone + naratriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nefazodone
  • Invega Trinza (paliperidone palmitate)
    +
    nefazodone
    1 interaction

    Caution Advised

    paliperidone + nefazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • orphenadrine
  • Invega Trinza (paliperidone palmitate)
    +
    orphenadrine
    1 interaction

    Caution Advised

    paliperidone + orphenadrine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • oxcarbazepine
  • Invega Trinza (paliperidone palmitate)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    paliperidone + oxcarbazepine

    caution advised: combo may decr. paliperidone levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (P-gp-mediated transport possibly induced; additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • paroxetine
  • Invega Trinza (paliperidone palmitate)
    +
    paroxetine
    1 interaction

    Caution Advised

    paliperidone + paroxetine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • passion flower
  • Invega Trinza (paliperidone palmitate)
    +
    passion flower
    1 interaction

    Caution Advised

    paliperidone + passion flower

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • perampanel
  • Invega Trinza (paliperidone palmitate)
    +
    perampanel
    1 interaction

    Caution Advised

    paliperidone + perampanel

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • pheniramine
  • Invega Trinza (paliperidone palmitate)
    +
    pheniramine
    1 interaction

    Caution Advised

    paliperidone + pheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • polyethylene glycol
  • Invega Trinza (paliperidone palmitate)
    +
    polyethylene glycol
    1 interaction

    Caution Advised

    paliperidone + polyethylene glycol

    caution advised, especially if polyethylene glycol bowel prep use: combo may incr. risk of seizures (additive effects)

  • polyethylene glycol/electrolytes
  • Invega Trinza (paliperidone palmitate)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Caution Advised

    paliperidone + polyethylene glycol/ electrolytes

    caution advised: combo may incr. risk of seizures (additive effects)

  • pyrilamine
  • Invega Trinza (paliperidone palmitate)
    +
    pyrilamine
    1 interaction

    Caution Advised

    paliperidone + pyrilamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ramelteon
  • Invega Trinza (paliperidone palmitate)
    +
    ramelteon
    1 interaction

    Caution Advised

    paliperidone + ramelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • repotrectinib
  • Invega Trinza (paliperidone palmitate)
    +
    repotrectinib
    1 interaction

    Caution Advised

    paliperidone + repotrectinib

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • revefenacin inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    revefenacin inhaled
    1 interaction

    Caution Advised

    paliperidone + revefenacin inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • rivastigmine
  • Invega Trinza (paliperidone palmitate)
    +
    rivastigmine
    1 interaction

    Caution Advised

    paliperidone + rivastigmine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • rizatriptan
  • Invega Trinza (paliperidone palmitate)
    +
    rizatriptan
    1 interaction

    Caution Advised

    paliperidone + rizatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rufinamide
  • Invega Trinza (paliperidone palmitate)
    +
    rufinamide
    1 interaction

    Caution Advised

    paliperidone + rufinamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • selinexor
  • Invega Trinza (paliperidone palmitate)
    +
    selinexor
    1 interaction

    Caution Advised

    paliperidone + selinexor

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sodium picosulfate
  • Invega Trinza (paliperidone palmitate)
    +
    sodium picosulfate
    1 interaction

    Caution Advised

    paliperidone + sodium picosulfate

    caution advised: combo may incr. risk of seizures (additive effects)

  • sofpironium topical
  • Invega Trinza (paliperidone palmitate)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    paliperidone + sofpironium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • solriamfetol
  • Invega Trinza (paliperidone palmitate)
    +
    solriamfetol
    1 interaction

    Caution Advised

    paliperidone + solriamfetol

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • stiripentol
  • Invega Trinza (paliperidone palmitate)
    +
    stiripentol
    1 interaction

    Caution Advised

    paliperidone + stiripentol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • sulfate bowel prep
  • Invega Trinza (paliperidone palmitate)
    +
    sulfate bowel prep
    1 interaction

    Caution Advised

    paliperidone + sulfate bowel prep

    caution advised: combo may incr. risk of seizures (additive effects)

  • sumatriptan
  • Invega Trinza (paliperidone palmitate)
    +
    sumatriptan
    1 interaction

    Caution Advised

    paliperidone + sumatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tasimelteon
  • Invega Trinza (paliperidone palmitate)
    +
    tasimelteon
    1 interaction

    Caution Advised

    paliperidone + tasimelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thiotepa
  • Invega Trinza (paliperidone palmitate)
    +
    thiotepa
    1 interaction

    Caution Advised

    paliperidone + thiotepa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tiagabine
  • Invega Trinza (paliperidone palmitate)
    +
    tiagabine
    1 interaction

    Caution Advised

    paliperidone + tiagabine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • tiotropium inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    paliperidone + tiotropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • topiramate
  • Invega Trinza (paliperidone palmitate)
    +
    topiramate
    1 interaction

    Caution Advised

    paliperidone + topiramate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • treosulfan
  • Invega Trinza (paliperidone palmitate)
    +
    treosulfan
    1 interaction

    Caution Advised

    paliperidone + treosulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • trihexyphenidyl
  • Invega Trinza (paliperidone palmitate)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    paliperidone + trihexyphenidyl

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • triprolidine
  • Invega Trinza (paliperidone palmitate)
    +
    triprolidine
    1 interaction

    Caution Advised

    paliperidone + triprolidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • trospium
  • Invega Trinza (paliperidone palmitate)
    +
    trospium
    1 interaction

    Caution Advised

    paliperidone + trospium

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • umeclidinium inhaled
  • Invega Trinza (paliperidone palmitate)
    +
    umeclidinium inhaled
    1 interaction

    Caution Advised

    paliperidone + umeclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • vaborbactam
  • Invega Trinza (paliperidone palmitate)
    +
    vaborbactam
    1 interaction

    Caution Advised

    paliperidone + vaborbactam

    caution advised: combo may decr. paliperidone levels, efficacy (P-gp-mediated transport possibly induced)

  • valerian
  • Invega Trinza (paliperidone palmitate)
    +
    valerian
    1 interaction

    Caution Advised

    paliperidone + valerian

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Invega Trinza (paliperidone palmitate)
    +
    valproic acid
    1 interaction

    Caution Advised

    paliperidone + valproic acid

    caution advised: combo may incr. paliperidone levels, risk of CNS depression, psychomotor impairment, other adverse effects; may alter seizure control (hepatic metabolism possibly inhibited, additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • vigabatrin
  • Invega Trinza (paliperidone palmitate)
    +
    vigabatrin
    1 interaction

    Caution Advised

    paliperidone + vigabatrin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

  • vilazodone
  • Invega Trinza (paliperidone palmitate)
    +
    vilazodone
    1 interaction

    Caution Advised

    paliperidone + vilazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • viloxazine
  • Invega Trinza (paliperidone palmitate)
    +
    viloxazine
    1 interaction

    Caution Advised

    paliperidone + viloxazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolmitriptan
  • Invega Trinza (paliperidone palmitate)
    +
    zolmitriptan
    1 interaction

    Caution Advised

    paliperidone + zolmitriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Invega Trinza (paliperidone palmitate)
    +
    zonisamide
    1 interaction

    Caution Advised

    paliperidone + zonisamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, paliperidone may decr. seizure threshold)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@3be4a5b5
  • QT prolongation
  • arrhythmia
  • AV block
  • stroke
  • TIA
  • hypotension, orthostatic
  • syncope
  • hyperthermia
  • neuroleptic malignant syndrome
  • extrapyramidal symptoms, severe
  • tardive dyskinesia
  • dystonia
  • hyperglycemia
  • diabetes mellitus
  • seizures
  • priapism
  • hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • leukopenia
  • neutropenia
  • agranulocytosis
  • dysphagia, severe

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@6cc3876f
  • hyperprolactinemia
  • dyslipidemia
  • headache
  • weight gain
  • injection site reaction
  • URI
  • agitation
  • hyperglycemia
  • anxiety
  • somnolence
  • extrapyramidal symptoms
  • akathisia
  • dizziness
  • vomiting
  • nausea
  • abdominal discomfort
  • abdominal pain
  • diarrhea
  • xerostomia
  • back pain
  • musculoskeletal pain
  • extremity pain
  • cough
  • insomnia
  • UTI
  • asthenia
  • fatigue
  • HTN
  • nightmares
  • fever
  • impaired body temperature regulation

Safety/Monitoring .

Monitoring Parameters
Cr at baseline; fasting lipid panel at baseline, then periodically; fasting glucose at baseline if diabetes risk factors, then periodically; CBC with diff frequently during initial tx if pre-existing or history of leukopenia/neutropenia; weight; consider orthostatic vital signs if hypotension risk

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 3rd trimester; risk of teratogenicity not expected based on limited human data, though risk of neonatal extrapyramidal and withdrawal symptoms based on human data with antipsychotics; no known risk of teratogenicity based on animal data at up to 10x MRHD

Pregnancy Registry

enroll patients or encourage patients to enroll in National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or www.womensmentalhealth.org/research/pregnancyregistry/atypicalantipsychotic

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm, though drug excreted into milk; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@59516199

Metabolism: for paliperidone: liver minimally; CYP450: minimal; 3A4 substrate

Excretion: for paliperidone: urine 80% (51-67% unchanged), feces 11%; Half-life: 25-49 days (1-mo IM form), 84-139 days (3-mo IM form), 148-159 days (6-mo IM form)

Subclass: Antipsychotics, 2nd generation

Mechanism of Action
for paliperidone: exact mechanism of action unknown; antagonizes dopamine D2 receptors, serotonin 5-HT2A receptors, others

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Janssen Pharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@4d0eb620

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

intramuscular suspension, extended release:

  • 819 mg (1 syringe, 2.625 mL): $8,810.00

intramuscular suspension, extended release:

  • 273 mg (1 syringe, 0.875 mL): $2,943.00

intramuscular suspension, extended release:

  • 410 mg (1 syringe, 1.315 mL): $4,410.00

intramuscular suspension, extended release:

  • 546 mg (1 syringe, 1.75 mL): $5,877.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information